Navigation Links
Lilly Reports First-Quarter 2011 Results
Date:4/18/2011

pite a significant decline in Gemzar sales due to generic competition. This revenue growth allowed us to make necessary investments in research and development to address the challenges of upcoming patent expirations. We are on track to deliver on our 2011 headcount and expense reduction targets, as well as our goal of having at least ten potential new medicines in Phase 3 clinical development by the end of this year."

Key Events Over the Last Three Months

  • The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending approval of exenatide 2 mg powder and solvent for prolonged release suspension for injection (proposed trade name Bydureon) in the European Union for the treatment of type 2 diabetes in combination with certain oral therapies. The CHMP's positive opinion is now referred for final action by the European Commission, which has the authority to approve medicines for the European Union. The Commission usually makes a decision on CHMP recommendations within two to three months.
  • Late last week, the company received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT), under investigation for the treatment of exocrine pancreatic insufficiency (EPI). The complete response letter communicated the need for Lilly to conduct an additional clinical trial prior to a re-submission. The company will be working diligently to address the agency's questions.
  • The company announced that Axiron® (testosterone) topical solution is available in pharmacies throughout the U.S.
  • The company received a complete response letter from the FDA for the NDA for Amyvid™ (florbetapir F 18 injection), a Positron Emission Tomography (PET) imaging agent under investigation for the detection of beta-amyloid plaque in the brain
    '/>"/>

  • SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
    2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
    3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
    4. Lilly Receives NCQA Design Certification for Depression Care Management Program
    5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
    6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
    7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
    8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
    9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
    10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
    11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/13/2014)... 13, 2014 Auf ... Tokio veranstalteten F&E-Tagung meldete Astellas ... Neuausrichtung seines Forschungsrahmenprogramms. Die Tagung bot Astellas ... fortgeschrittenen klinischen Programme und die Konzernstrategie des ... bestand darin, aktuelle Meldungen zu den Astellas-Initiativen ...
    (Date:7/11/2014)... N.C. , July 11, 2014 ... approaches are evolving across industry sectors to better ... examining better ways to engage with and understand ... inform themselves and make critical purchasing decisions. ... firm, Best Practices, LLC, one area where organizations ...
    (Date:7/11/2014)... DUBLIN , July 11, 2014 ... "Global Hypodermic Needles Market 2014-2018" report to ... A hypodermic needle is a hollow needle ... the body or or to extract fluids from it. ... liquids or to inject substances that cannot be ingested. ...
    Breaking Medicine Technology:Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 2Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 3Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 4New Technologies Transforming Consumer Marketing Research Playbook 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3
    (Date:7/14/2014)... July 14, 2014 — ... cloud management, governance, and compliance software solutions for ... will be available to customers of Rackspace, ... , The hosting and value-added reseller (VAR) agreements ... solutions to new or existing customers: , Backup: ...
    (Date:7/14/2014)... July 14, 2014 “You've probably heard ... exactly does that mean?” This question was posed in ... on Western Washington Medical Group’s blog regarding how people ... health in mind . , According to the article, ... placing themselves at a high risk of dehydration and ...
    (Date:7/14/2014)... Sometimes, thinking “inside the box” can be revolutionary. ... product release, Joyboxx™ - The world’s only hygienic and ... Inventor and CEO, Deborah Semer began designing a safe ... for their ‘toys’ after she realized no such product ... Semer met 30-year industry veteran Phyllis Heppenstall, the legendary ...
    (Date:7/14/2014)... new analysis has found that rates of testicular cancer ... Hispanic American men, but not among their non-Hispanic counterparts. ... journal of the American Cancer Society, the findings indicate ... of testicular cancer in Hispanic adolescents and young adults, ... cause of this trend. , Testicular cancer is one ...
    (Date:7/14/2014)... According to the Blood Pressure Solution book review recently ... a series of new information on high blood pressure ... can help readers understand more about blood pressure. The book ... methods to control hypertension naturally. , Blood ... penned by Ken Burge, a medical researcher and health consultant. ...
    Breaking Medicine News(10 mins):Health News:AvePoint Works with Rackspace to Extend Vital Management Features to Hybrid SharePoint Deployments 2Health News:AvePoint Works with Rackspace to Extend Vital Management Features to Hybrid SharePoint Deployments 3Health News:Drink With Your Mental Health in Mind, Advises an Article by Mental Health America Featured by Western Washington Medical Group 2Health News:Passionate Playground launches Joyboxx 2Health News:Passionate Playground launches Joyboxx 3Health News:Testicular cancer rates are on the rise in young Hispanic Americans 2Health News:Blood Pressure Solution Book Review Exposes Ken Burge's Hypertension Treatment Guide – Vkool.com 2Health News:Blood Pressure Solution Book Review Exposes Ken Burge's Hypertension Treatment Guide – Vkool.com 3
    ... and productivity , , TUESDAY, Sept. 25 (HealthDay News) -- ... program that used a care manager to guide them ... well as greater productivity. , The authors of the ... of the Journal of the American Medical Association ...
    ... of the Combat Soldiers Recovery Fund, announced that there ... Wednesday evening,September 26, 2007. According to Ms. Miller, "100% ... soldiers or their immediate family, with no,reductions for overhead ... "the Fund has distributed $70,000 so far,and is now ...
    ... of Boise,s Leadership in the ... Premium and Specialty Papers Market, BENSENVILLE, Ill., ... today announced that Boise(R) BEWARE(TM), an,anti-copy/anti-scan paper is in compliance ... The legislation,will go into affect on October 1, 2007. ...
    ... Life Sciences, LLC, an,Indiana based company, has introduced ... about the growing health risks associated,with diabetes. This ... and,antioxidant-rich dietary supplement that has been scientifically proven ... two conditions,that most often lead to Type II ...
    ... Experts in health care and,technology investment discussed objectives, ... growth in Ohio today at the Ohio,Capital Fund,s ... will help,shape Ohio,s future as it rebounds from ... the State of Ohio is changing," said Paul,Cohn ...
    ... open its doors to area ... youths on September 28, PORTLAND, Ore., Sept. 25 ... to play, learn and grow with,the grand opening of the Regence Boys & ... grant from Regence,the largest in the company,s history. The facility is Portland,s first,completely ...
    Cached Medicine News:Health News:Treatment Programs Benefit Depressed Workers 2Health News:Treatment Programs Benefit Depressed Workers 3Health News:Boise(R) BEWARE(TM) Meets New Federal Guidelines Set Forth by Medicaid 2Health News:New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced 2Health News:New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced 3Health News:Experts Agree. Ohio's Technology Investment Future Looks Bright 2Health News:Experts Agree. Ohio's Technology Investment Future Looks Bright 3Health News:Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization 2Health News:Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization 3
    ... seamless eliminating the possibility of leakage around glued ... temperature resistant gel trays meaning you do no ... added user friendliness, the Primo tanks come with ... The Primo Gel Systems are designed to be ...
    ... up and safe to use, the Gel XL ... and running agarose gels. The unit is compact, ... power supply eliminates a tangled mess of leads ... Designed for safety and convenience, the power supply ...
    ... HE 33 Mini Submarine Unit for nucleic acid analysis ... designed for very fast separations of DNA restriction fragments ... a heat-sink. Fill the base with coolant and seal. ... keeping the unit in a freezer or by immersing ...
    ... 2000 apparatus and ready-to-use gels are the ... of nucleic acids by submerged gel electrophoresis. ... system, offering full compatibility and optimal performance, ... SEA 2000 and a unique staining tray, ...
    Medicine Products: